News

BioAdvance WorkShop

ImmunoGenesis Expands R&D, Clinical and Business Development Teams and Opens Research Laboratory
Annovis Bio Reports Positive Safety Data from its Phase 2 Alzheimer’s Study
Relmada Therapeutics Announces the Acquisition of Development and Commercial Rights to Novel Psilocybin and Derivates Program from Arbormentis LLC
Ride Health and the American Heart Association Partner to Improve Health Equity for Patients Facing Transportation Barriers
Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing